New drug duo aims to shrink tough breast cancer before surgery

NCT ID NCT07371208

Summary

This study is testing a combination of two drugs, Sac-TMT and KL-A167, as a treatment given before surgery for triple-negative breast cancer. The goal is to see if this combination can effectively shrink or eliminate the tumor and is safe for patients. The trial will enroll about 40 people with this specific type of breast cancer who have not yet had any cancer treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Shanghai Jiaotong University School of Medicine affiliated Ruijin Hospital

    RECRUITING

    Shanghai, Shanghai Municipality, 200025, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.